Based on our advanced algorithm, we predict that FOLD stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $5.8, while the 1-week outlook suggests a value of $5.27. For the 1-month forecast, we project a price of $5.04. Looking further ahead, our 2026 projection estimates a value of $8.83, with a long-term 2030 forecast reaching $17.34. Stay informed and make strategic decisions with our data-driven insights!
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. FOLD has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
FOLD stock price ended at $6.06 on Friday, after losing-3.5%
The Amicus Therapeutics Inc stock price decreased by -3.5% on the last trading day (25 Jul 2025), dropping from 6.27 to 6.06. Throughout the last trading session, the stock experienced a fluctuation of 5.36% , ranging from a day low of $5.97 to a day high of 6.29. The price has declined in 4 of the last 10 days, resulting in a total change of -0.49% during this period. On the last day, trading volume increase by 422.99K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 3.51M shares were traded, amounting to approximately 21.20M.
FOLD Technical Signals
FOLD(Amicus Therapeutics Inc Corp) has 3 buy signals and 5 sell signals now. The current trend is uptrend starting from 2025-07-15. The total price change during this trend is +2.54%. Recently, the price has decreased with an increase in volume, indicating a strong bearish signal. The average turnover of FOLD over the last 5 trading days is 21.05M. Overall, the technical indicator signals lean more toward a Bearish outlook in the mid-term.
FOLD Moving Average Analysis
Amicus Therapeutics Inc's overall moving average trend leans more bearish as of Monday, July 28, 2025, with 3 negative signals and 1 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $6.81, and $7.15. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $5.71, and $5.37. A break-down below any of these levels will issue sell signals.
FOLD Short Selling Analysis
The short sale ratio of Amicus Therapeutics Inc(FOLD) as of 25 Jul 2025 is 16.87%, dropping from last trading day. With decreasing price from 6.28 to 6.06. The short sell activity indicate that short sellers may be anticipating price hit a bottom.
Technical Signal
Technical Signals Summary
Sell
Sell
5
Buy
3
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
3 Bullish Signals
3 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
0.139
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.0308
Bullish
Moving Average
10-day SMA crosses above 60-day SMA
--
Bullish
5 Bearish Signals
5 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
In 2026, Amicus Therapeutics Inc (FOLD) is anticipated to change hands in a trading channel between $4.97 and $10.50.
Amicus Therapeutics Inc Stock Forecast 2026
Jan 2026: FOLD Stock Forecast
Potential ROI: 55.99%
In Jan 2026, Amicus Therapeutics Inc's value is forecasted to reach an average price of $8.83. The price is predicted to fluctuate between a low of $8.71 and a high of $9.18.
Feb 2026: FOLD Stock Forecast
Potential ROI: 50.28%
In Feb 2026, Amicus Therapeutics Inc's value is forecasted to reach an average price of $8.51. The price is predicted to fluctuate between a low of $7.29 and a high of $9.29.
Mar 2026: FOLD Stock Forecast
Potential ROI: 25.02%
In Mar 2026, Amicus Therapeutics Inc's value is forecasted to reach an average price of $7.08. The price is predicted to fluctuate between a low of $6.45 and a high of $7.88.
Apr 2026: FOLD Stock Forecast
Potential ROI: 31.52%
In Apr 2026, Amicus Therapeutics Inc's value is forecasted to reach an average price of $7.44. The price is predicted to fluctuate between a low of $7.30 and a high of $7.80.
May 2026: FOLD Stock Forecast
Potential ROI: 14.67%
In May 2026, Amicus Therapeutics Inc's value is forecasted to reach an average price of $6.49. The price is predicted to fluctuate between a low of $5.94 and a high of $7.41.
Jun 2026: FOLD Stock Forecast
Potential ROI: 14.67%
In Jun 2026, Amicus Therapeutics Inc's value is forecasted to reach an average price of $6.49. The price is predicted to fluctuate between a low of $6.32 and a high of $6.82.
Jul 2026: FOLD Stock Forecast
Potential ROI: 55.99%
In Jul 2026, Amicus Therapeutics Inc's value is forecasted to reach an average price of $8.83. The price is predicted to fluctuate between a low of $7.45 and a high of $10.16.
Aug 2026: FOLD Stock Forecast
Potential ROI: 42.30%
In Aug 2026, Amicus Therapeutics Inc's value is forecasted to reach an average price of $8.05. The price is predicted to fluctuate between a low of $7.44 and a high of $9.41.
Sep 2026: FOLD Stock Forecast
Potential ROI: 40.88%
In Sep 2026, Amicus Therapeutics Inc's value is forecasted to reach an average price of $7.97. The price is predicted to fluctuate between a low of $6.71 and a high of $8.55.
Oct 2026: FOLD Stock Forecast
Potential ROI: 39.66%
In Oct 2026, Amicus Therapeutics Inc's value is forecasted to reach an average price of $7.90. The price is predicted to fluctuate between a low of $6.80 and a high of $9.10.
Nov 2026: FOLD Stock Forecast
Potential ROI: 16.64%
In Nov 2026, Amicus Therapeutics Inc's value is forecasted to reach an average price of $6.60. The price is predicted to fluctuate between a low of $4.97 and a high of $6.65.
Dec 2026: FOLD Stock Forecast
Potential ROI: 55.69%
In Dec 2026, Amicus Therapeutics Inc's value is forecasted to reach an average price of $8.81. The price is predicted to fluctuate between a low of $7.93 and a high of $10.50.
FOLD Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Amicus Therapeutics Inc(FOLD), our algorithm predicts FOLD's 1-month price at $5.45, with an -10.08%downwardshift. Using a similarity score up to 91.80%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Amicus Therapeutics Inc (FOLD.O) stock, as of Sunday, July 27, 2025 , forecasts a -10.08% change over the next month, based on its high correlation with ADMA.O stock patterns. The similarity between their price movements over the analyzed periods is 91.8%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
FOLD
Future prediction
Up: -10.08%
ADMA
Down: -10.08%Similarity: 91.8%
Name
Similarity
Up/Down
ADMA.O
91.80%
-10.08%
PMCB.O
91.15%
+2.81%
ULH.O
91.09%
-7.06%
TEAM.O
91.07%
-0.94%
SB.N
91.07%
-9.06%
CLH.N
90.85%
+12.42%
ATS.N
90.70%
-19.63%
TSN.N
90.58%
+3.54%
CRS.N
90.53%
+4.17%
FOLD Seasonality Analysis
Based on FOLD's historical stock price data across all years, the probability of a positive return in July is54.55%, suggesting it maybe an ideal month to invest in FOLD. In contrast,Juneoffers the highest probability of positive returns at72.73%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Amicus Therapeutics Inc (FOLD.O) stock in June has the highest probability of a positive return (72.73%), while September has the lowest probability (20.00%).
Performance Seasonality
The chart shows Amicus Therapeutics Inc. (FOLD)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Should I buy Amicus Therapeutics Inc (FOLD.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. FOLD has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Amicus Therapeutics Inc (FOLD.O) stock in a year?
The radar chart shows that buying Amicus Therapeutics Inc (FOLD.O) stock in June has the highest probability of a positive return (72.73%), while September has the lowest probability (20.00%).
How has Amicus Therapeutics Inc. (FOLD)'s stock price performed over the past three years?
FOLD's stock price rose by 18.94% in 2023,decreased by -33.85% in 2024, and went down by 34.91%in 2025.
Which bull technical signals does FOLD have?
Bullish technical signals of FOLD include: AO_5_34 > 0, MACD_12_26_9 > 0, 10-day SMA crosses above 60-day SMA.
Is FOLD a buy based on overall technical signals summary?
FOLD has 3 buy signals and 5 sell signals now. Overall the technical rating for FOLD is Sell . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of FOLD.
What is the trend of Amicus Therapeutics Inc (FOLD)'s moving average?
Amicus Therapeutics Inc's overall moving average trend leans more bearish as of July 28 2025, with 3 negative signals and 1 positive signal.
What is price prediction for FOLD stock next month?
The price prediction chart for Amicus Therapeutics Inc (FOLD.O) stock, as of July 27 2025, forecasts a -10.08% change over the next month, based on its high correlation with ADMA stock patterns. The similarity between their price movements over the analyzed periods is 91.8%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for FOLD Stock?
### **Price Prediction for FOLD Stock in 2025**
FOLD stock is predicted to trade between **$5.50 and $7.50** in 2025.
The stock is currently undervalued with positive catalysts, including the DMX-200 licensing agreement, but faces technical resistance near $7.50.
What is price prediction 2030 for FOLD Stock?
### **Price Prediction for FOLD Stock by 2030**
Based on current trends and analysis, here is a concise prediction for FOLD stock:
1. **Bullish Scenario**: FOLD stock could reach **$18-$22** by 2030, driven by successful Phase 3 trial results for DMX-200 and potential FDA approval, enhancing its pipeline and revenue prospects.
2. **Bearish Scenario**: The stock may trade between **$4-$6** if clinical trials face setbacks or market competition intensifies.
3. **Conservative Estimate**: A moderate growth trajectory suggests FOLD could stabilize around **$10-$12** by 2030, supported by its current pipeline and market position.
**Reasons**:
- The licensing agreement with Dimerix for DMX-200 positions FOLD strategically in the rare disease market.
- Positive interim trial data and FDA alignment on endpoints increase the likelihood of approval.
- The biotech sector's volatility and FOLD's high valuation metrics indicate significant potential but also risks.